Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
PD153035 HCL
Cat No.
CEI-0016
Description
PD153035 can inhibit epidermal growth factor (EGF) receptor tyrosine kinase with Ki of 6 pM.
CAS No.
183322-45-4
Molecular Weight
396.67
Purity
>99%
Storage
2 years at -20 centigrade
Targets
EGFR
Molecular Formula
C16H14BrN3O2.HCl
Chemical Name
N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride
Solubility
DSMO 0.5 mg/mL Water
In vitro
PD153035 can inhibit epidermal growth factor (EGF) receptor tyrosine kinase with Ki of 6 pM. PD153035 can potently suppresses tyrosine phosphorylation of the EGF receptor in A431 cells at nanomolar concentrations. PD153035 inhibits EGF-dependent EGF receptor phosphorylation and suppresses the proliferation and clonogenicity of a wide panel of EGF receptor-overexpressing human cancer cell lines. EGF receptor autophosphorylation in response to exogenous EGF was completely inhibited at PD153035 concentrations of >75 nM in cells overexpressing the EGF receptor.
In vivo
In A431 human epidermoid tumors grown as xenografts in immunodeficient nude mice, PD153035(80 mg/kg) suppresse the tyrosine phosphorylation of the EGF receptor rapidly by 80-90% in the tumors.
Download
Download Datasheet